Astrazeneca pause is a good thing: Stat News' Adam Feuerstein
Published
Sep 09 2020 at 8:15 PM GMT
Key
Points
Points
- Astrazeneca has paused its Covid vaccine clinical trials after a volunteer participant had neurological symptoms.
- Adam Feuerstein, Stat News, joins CNBC's Meg Tirrell on 'Power Lunch' to discuss how he broke the story and what it could mean for Astrazeneca.
-
Posted in Business
Trending
Stats
- Published Sep 9, 2020 8:15 PM GMT